Literature DB >> 28483810

Evidentiary Support in Public Comments to the FDA's Center for Tobacco Products.

Natalie Hemmerich1, Elizabeth G Klein1, Micah Berman1.   

Abstract

Electronic Nicotine Delivery Systems (ENDS) were introduced into the US market in 2007, and until recently these devices were unregulated at the federal level. In 2014, the US Food and Drug Administration (FDA) published a Notice of Proposed Rulemaking asserting its intention to regulate ENDS and requesting public comments on numerous related issues, including potential limits on the sale of flavored ENDS. This article analyzes key comments submitted to the FDA on the issue of flavor regulation in ENDS and examines the weight and credibility of the evidence presented by both supporters and opponents of regulation. It also describes the final deeming rule, published in May 2016, and the FDA's response to the evidence submitted. This is the first study to examine public comments submitted to the FDA's Center for Tobacco Products, and it concludes that opponents of regulation were more likely to rely on sources that were not peer reviewed and that were affected by conflicts of interest. In light of these findings, the FDA and the research community should develop processes to carefully and critically analyze public comments submitted to the FDA on issues of tobacco regulation.
Copyright © 2017 by Duke University Press.

Entities:  

Keywords:  Food and Drug Administration; deeming; electronic nicotine delivery systems; flavors; tobacco regulatory science

Mesh:

Substances:

Year:  2017        PMID: 28483810      PMCID: PMC5522345          DOI: 10.1215/03616878-3856121

Source DB:  PubMed          Journal:  J Health Polit Policy Law        ISSN: 0361-6878            Impact factor:   2.265


  22 in total

1.  Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry.

Authors:  David Garne; Megan Watson; Simon Chapman; Fiona Byrne
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

Review 2.  Did regulators fail over selective serotonin reuptake inhibitors?

Authors:  David Healy
Journal:  BMJ       Date:  2006-07-08

3.  The Impact of Trying Electronic Cigarettes on Cigarette Smoking by College Students: A Prospective Analysis.

Authors:  Erin L Sutfin; Beth A Reboussin; Beata Debinski; Kimberly G Wagoner; John Spangler; Mark Wolfson
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

Review 4.  Electronic Cigarettes—A Narrative Review for Clinicians.

Authors:  Menfil A Orellana-Barrios; Drew Payne; Zachary Mulkey; Kenneth Nugent
Journal:  Am J Med       Date:  2015-02-27       Impact factor: 4.965

5.  Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011.

Authors:  Brian A King; Suhana Alam; Gabbi Promoff; Rene Arrazola; Shanta R Dube
Journal:  Nicotine Tob Res       Date:  2013-02-28       Impact factor: 4.244

6.  Quantifying The Food And Drug Administration's rulemaking delays highlights the need for transparency.

Authors:  Thomas J Hwang; Jerry Avorn; Daniel Carpenter; Aaron S Kesselheim
Journal:  Health Aff (Millwood)       Date:  2014-02       Impact factor: 6.301

7.  Candy flavorings in tobacco.

Authors:  Jessica E Brown; Wentai Luo; Lorne M Isabelle; James F Pankow
Journal:  N Engl J Med       Date:  2014-05-07       Impact factor: 91.245

8.  Flavored tobacco product use among U.S. young adults.

Authors:  Andrea C Villanti; Amanda Richardson; Donna M Vallone; Jessica M Rath
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

9.  Adolescent males' awareness of and willingness to try electronic cigarettes.

Authors:  Jessica K Pepper; Paul L Reiter; Annie-Laurie McRee; Linda D Cameron; Melissa B Gilkey; Noel T Brewer
Journal:  J Adolesc Health       Date:  2012-11-30       Impact factor: 5.012

10.  A critical evaluation of the volume, relevance and quality of evidence submitted by the tobacco industry to oppose standardised packaging of tobacco products.

Authors:  Jenny L Hatchard; Gary J Fooks; Karen A Evans-Reeves; Selda Ulucanlar; Anna B Gilmore
Journal:  BMJ Open       Date:  2014-02-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.